Velpatasvir and sofosbuvir: How will we use a new drug when the old agents work well?

Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.

Share Velpatasvir and sofosbuvir: How will we use a new drug when the old agents work well?

Sign up to save your podcasts

Velpatasvir and sofosbuvir: How will we use a new drug when the old agents work well?

Velpatasvir and sofosbuvir: How will we use a new drug when the old agents work well?